Terms: = Leukemia AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
10 results:
1. A deconvolution method and its application in analyzing the cellular fractions in acute myeloid leukemia samples.
Li H; Sharma A; Ming W; Sun X; Liu H
BMC Genomics; 2020 Sep; 21(1):652. PubMed ID: 32967610
[TBL] [Abstract] [Full Text] [Related]
2. Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia.
Han H; Byun JM; Shin DY; Yoon SS; Koh Y; Hong J; Kim I; Lee C; Yoo H; Yun H; Kim MJ; Cho SI; Seong MW; Park SS
Korean J Intern Med; 2021 Mar; 36(2):401-412. PubMed ID: 32811132
[TBL] [Abstract] [Full Text] [Related]
3. Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets.
Hoell JI; Ginzel S; Kuhlen M; Kloetgen A; Gombert M; Fischer U; Hein D; Demir S; Stanulla M; Schrappe M; Zur Stadt U; Bader P; Babor F; Schuster F; Strahm B; Alten J; Moericke A; Escherich G; von Stackelberg A; Thiele R; McHardy AC; Peters C; Bornhauser B; Bourquin JP; Krause S; Enczmann J; Meyer LH; Eckert C; Borkhardt A; Meisel R
Blood Adv; 2019 Oct; 3(20):3143-3156. PubMed ID: 31648313
[TBL] [Abstract] [Full Text] [Related]
4. Clonal evolution mechanisms in nt5c2 mutant-relapsed acute lymphoblastic leukaemia.
Tzoneva G; Dieck CL; Oshima K; Ambesi-Impiombato A; Sánchez-Martín M; Madubata CJ; Khiabanian H; Yu J; Waanders E; Iacobucci I; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Kirschner-Schwabe R; Mullighan CG; Rabadan R; Ferrando AA
Nature; 2018 Jan; 553(7689):511-514. PubMed ID: 29342136
[TBL] [Abstract] [Full Text] [Related]
5. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
[TBL] [Abstract] [Full Text] [Related]
6. [PRPS1 Expression in Children with Acute leukemia and Its Clinical Significance].
Ma YM; An XZ; Guan XM; Kong QL; Li PF; Xian Y; Xiao JW; Meng Y; Liang SY; Yu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):311-317. PubMed ID: 28446267
[TBL] [Abstract] [Full Text] [Related]
7. [nt5c2 expression in children with acute leukemia and its clinical significance].
Wang Y; An X; Liu J; Zhang N; Liu Z; Liang S; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):748-53. PubMed ID: 26462774
[TBL] [Abstract] [Full Text] [Related]
8. Relapse-specific mutations in nt5c2 in childhood acute lymphoblastic leukemia.
Meyer JA; Wang J; Hogan LE; Yang JJ; Dandekar S; Patel JP; Tang Z; Zumbo P; Li S; Zavadil J; Levine RL; Cardozo T; Hunger SP; Raetz EA; Evans WE; Morrison DJ; Mason CE; Carroll WL
Nat Genet; 2013 Mar; 45(3):290-4. PubMed ID: 23377183
[TBL] [Abstract] [Full Text] [Related]
9. Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.
Krivtsov AV; Figueroa ME; Sinha AU; Stubbs MC; Feng Z; Valk PJ; Delwel R; Döhner K; Bullinger L; Kung AL; Melnick AM; Armstrong SA
Leukemia; 2013 Apr; 27(4):852-60. PubMed ID: 23235717
[TBL] [Abstract] [Full Text] [Related]
10. BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.
Perrotti D; Harb JG
Leuk Lymphoma; 2011 Feb; 52 Suppl 1(Suppl 1):30-44. PubMed ID: 21299458
[TBL] [Abstract] [Full Text] [Related]
